Prescription Drug Monitoring Programs (PDMP)- Data as a tool to reduce opioid-related harm

Posted on January 09, 2023

Pharmacist Academic Detailer Speaker:
Please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/ for a list of potential speakers.

Disclosure (s): For the latest disclosure information, please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/

The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.

  • Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Caladrius Biosciences Inc, Clover Health Investments Corp, Diffusion Pharmaceuticals Inc, Dynavax Technologies Corp, Gilead Sciences Inc, Glasko Smith Kline, Haleon, lmmunocellular Therapeutics, Motus GI Holdings Inc, Novabay Pharmaceuticals Inc, Novavax Inc, Ocugen Inc, Pfizer Inc, Protalix Biotherapeutics Inc, PuImatrix Inc, Quince Therapeutics Inc, Salarius Pharmaceuticals inc, Synthetic Biologics Inc, and Vaccinex Inc.
  • Speaker, Dr. Stewart Chung has stock ownership with companies Takeda and Silo Pharmaceutical.
  • Speaker, Dr. Judith Jakuszewski has stock ownership with Pfizer.

All relevant financial relationships listed for the above speakers have been mitigated.

Type of Activity: Knowledge-based

Learning Objectives:

  • Describe the impact that prescription drug monitoring programs have had on reducing opioid-related harm
  • Discuss the responsibilities of the pharmacist and prescriber in using the PDMP
Target Audience: Pharmacists Fee: Free
Release Date: January 9, 2023 Expiration Date: February 17, 2024
Estimated time to complete: 0.5 hours CE: 0.5 contact hours (0.05 CEUs)

Go to activity

ACPE logo
The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-23-003-H03-P, for 0.5 contact hours (0.05 CEUs). Attendance at the entire knowledge-based activity, completion of the pre and post-test and the evaluation form, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s). All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e- Profile visit: www.MyCPEmonitor.net.

How to Earn Credit:
Participants must complete the activity as described above in the Continuing Education Statements by attending the entire academic detailing session, completing a pre and post-test, and successfully submitting an activity evaluation. A certificate of completion or uploading of CPE credits to CPE Monitor will be issued after all requirements as described are completed.

Hardware/Software and Internet Requirements can be found at https://ce.pharmacy.uic.edu/online-activities/requirements/.

Provider Contact Information:
For general information please call the Office of Continuing Education and Meeting Services toll-free at (866) PHARM-CE (866-742-7623) or send an e-mail to: pharmce@uic.edu. Copyright © 2023– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on July 13, 2023